Law360, New York (November 4, 2008, 12:00 AM EST) -- Following a protracted battle over whether a patent related to Shire Laboratories Inc.'s anti-seizure drug Carbatrol should be included in a suit contesting a generic version of the medication, a federal judge has granted summary judgment of noninfringement to generic drugmaker Corepharma LLC.
U.S. District Judge Stanley R. Chesler of the U.S. District Court for the District of New Jersey handed down an order granting Corepharma's renewed motion for summary judgment on Friday, just weeks after refusing to grant a separate summary judgment motion on a...
Judge: Corepharma Did Not Infringe Carbatrol Patent
To view the full article, register now.
Try Law360 FREE for seven days
Already a subscriber? Click here to login
